Company Filing History:
Years Active: 2025
Title: Victoria Trantow: Innovator in Lipid Nanoparticle Technology
Introduction
Victoria Trantow is a prominent inventor based in Natick, MA (US). She has made significant contributions to the field of pharmaceutical technology, particularly in the development of lipid nanoparticle formulations. Her innovative work focuses on enhancing the delivery of therapeutic agents to target cells effectively.
Latest Patents
Victoria Trantow holds 1 patent for her invention titled "Lipid nanoparticle compositions and uses thereof." This patent describes a lipid nanoparticle (LNP) formulation that includes at least one sialic acid (SA)-containing lipid. The formulation is designed to effectively bind to cell surface Siglecs, transfect certain cells in vitro, and target specific cells in vivo. The invention also outlines methods for utilizing these LNP compositions in pharmaceutical applications, particularly for the intracellular delivery of nucleic acid therapeutics.
Career Highlights
Victoria Trantow is currently associated with Cytodigm, Inc., where she continues to advance her research in lipid nanoparticle technology. Her work is pivotal in the development of new therapeutic strategies that leverage the unique properties of lipid nanoparticles.
Collaborations
Victoria collaborates with Heliang Song, contributing to the innovative research environment at Cytodigm, Inc. Their combined expertise enhances the potential for groundbreaking advancements in the field.
Conclusion
Victoria Trantow's contributions to lipid nanoparticle technology exemplify her commitment to advancing pharmaceutical applications. Her innovative patent and ongoing work at Cytodigm, Inc. position her as a key figure in the field of drug delivery systems.